Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis

被引:0
作者
Krzysztof Sitko
Marta Bednarek
Jagoda Mantej
Magdalena Trzeciak
Stefan Tukaj
机构
[1] University of Gdańsk,Department of Molecular Biology, Faculty of Biology
[2] Medical University of Gdańsk,Department of Dermatology, Venerology and Allergology
来源
Cell Stress and Chaperones | 2021年 / 26卷
关键词
Atopic dermatitis, AD; Allergy; IgE; Autoimmunity; Autoantibodies; Heat shock proteins, Hsps; Hsp90;
D O I
暂无
中图分类号
学科分类号
摘要
Atopic dermatitis (AD) is one of the most common chronic inflammatory dermatoses characterized by persistent itching and recurrent eczematous lesions. While the primary events and key drivers of AD are topics of ongoing debate, cutaneous inflammation due to inappropriate IgE (auto)antibody–related immune reactions is frequently considered. Highly conserved and immunogenic heat shock protein 90 (Hsp90), a key intra- and extracellular chaperone, can activate the immune response driving the generation of circulating anti-Hsp90 autoantibodies that are found to be elevated in several autoimmune disorders. Here, for the first time, we observed that serum levels of Hsp90 and anti-Hsp90 IgE autoantibodies are significantly elevated (p < 0.0001) in AD patients (n = 29) when compared to age- and gender-matched healthy controls (n = 70). We revealed a positive correlation (0.378, p = 0.042) between serum levels of Hsp90 and the severity of AD assessed by Scoring Atopic Dermatitis (SCORAD). In addition, seropositivity for anti-Hsp90 IgE has been found in 48.27% of AD patients and in 2.85% of healthy controls. Although further studies on a larger group of patients are needed to confirm presented data, our results suggest that extracellular Hsp90 and autoantibodies to Hsp90 deserve attention in the study of the mechanisms that promote the development and/or maintenance of atopic dermatitis.
引用
收藏
页码:1001 / 1007
页数:6
相关论文
共 205 条
[1]  
Albani S(1995)Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis Nat Med 1 448-452
[2]  
Keystone EC(2019)Atopic dermatitis endotypes and implications for targeted therapeutics J Allergy Clin Immunol 143 1-11
[3]  
Nelson JL(2007)Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study Clin Exp Dermatol 32 311-313
[4]  
Ollier WER(2004)Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness Nat Cell Biol 6 507-514
[5]  
La Cava A(2013)Inhibition of HSP90 molecular chaperones: moving into the clinic Lancet Oncol 14 e358-369
[6]  
Montemayor AC(2013)New era of biologic therapeutics in atopic dermatitis Expert Opin Biol Ther 13 549-561
[7]  
Weber DA(2010)A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis Br J Dermatol 162 397-403
[8]  
Montecucco C(2005)Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding Structure 13 579-590
[9]  
Martini A(2011)Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets Blood 117 6135-6142
[10]  
Carson DA(2018)Targeting IgE antibodies by Immunoadsorption in atopic dermatitis Front Immunol 9 254-843